Episode 10: Biology Is The Software

This is the finale that completes the arc the series began with. The idea that launched this series was a mapping of the technology supercycle - from IBM mainframe through PC, internet, mobile, data, cloud, and chips to AGI - and the question of what the equivalent biological platform arc looks like for investors. Episode 1 introduced the six-wave framework that answered that question at the macro level. This finale returns to that original question and answers it fully, for Wave 6 specifically - the convergence of AI, synthetic biology, BCI, and mRNA in an era where intelligence is the substrate and biology is the software.If you listened, you would have nine episodes of context and understand the generics trap, the biologics scorecard, the CDMO qualification mechanics, the GLP-1 commodity lesson, the AI talent war, the capital allocation gap, the commercial model disintermediation, and the culture gap. This episode does not repeat any of that. It uses all of it as the foundation for a genuinely forward-looking argument about what Wave 6 actually is, what it means in practice today, and where the wealth will concentrate.Listen in to Episode 10 - the Series Finale - of the Bio-Health Supercycle.“My Pharma Reviews - The Podcast” is now available for you to listen on your favourite podcasting apps like Spotify and Apple. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit mypharmareviews.substack.com